State of the science in cervical cancer: Where we are today and where we need to go-Reference-Cited by-同舟云学术

State of the science in cervical cancer: Where we are today and where we need to go

Published:2014-04-15 Issue:15 Volume:120 Page:2282-2288
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Dizon Don S.¹²,Mackay Helen J.³⁴,Thomas Gillian M.⁵⁶,Werner Theresa L.⁷,Kohn Elise C.⁸,Hess Dina⁹,Rose Peter G.¹⁰,Covens Allan L.¹¹

Affiliation:

1. Gillette Center for Gynecologic Oncology; Massachusetts General Hospital Cancer Center; Boston Massachusetts

2. Department of Medicine; Harvard Medical School; Boston Massachusetts

3. Division of Medical Oncology and Hematology; Princess Margaret Hospital; Toronto Ontario Canada

4. Department of Medicine; University of Toronto; Toronto Ontario Canada

5. Department of Radiation Oncology, Sunnybrook Health Sciences Centre; University of Toronto; Toronto Ontario Canada

6. Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre; University of Toronto; Toronto Ontario Canada

7. Division of Oncology, Department of Medicine; University of Utah School of Medicine; Salt Lake City Utah

8. Gynecologic Cancer Therapeutics, Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis; National Cancer Institute; Bethesda Maryland

9. National Cancer Institute Gynecologic Oncology Steering Committees, EMMES Corporation; Rockville Maryland

10. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology; Cleveland Clinic Foundation; Cleveland Ohio

11. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Center; University of Toronto; Toronto Ontario Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28722/fullpdf

Reference38 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix;Perez;Int J Radiat Oncol Biol Phys,1998

3. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study;Rose;J Clin Oncol,2007

4. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer;Rose;N Engl J Med,1999

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation of Gene Expression Data Into Personalized Treatment in Cervical Cancer: Machine Learning Approach;Indian Journal of Gynecologic Oncology;2024-04-28

2. GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition;Brazilian Journal of Medical and Biological Research;2024

3. Development and validation of a radiomics-based nomogram for the prediction of postoperative malnutrition in stage IB1-IIA2 cervical carcinoma;Frontiers in Nutrition;2023-02-03

4. Identification of hub genes and role of CDKN2A as a biomarker in cervical cancer: An in-silico approach;Human Gene;2022-09

5. Down-regulated Circ_0000190 promotes cervical cancer by facilitating the activity of proto-oncogene protein EIF4E;Cell Cycle;2022-04-13